NCT00518960View on ClinicalTrials.gov

The Effects of ProAlgaZyme on HDL Cholesterol in Individuals With Metabolic Syndrome

NAUnknownINTERVENTIONAL
Enrollment

28

Participants

Timeline

Start Date

April 30, 2007

Study Completion Date

September 30, 2007

Conditions
Metabolic SyndromeHyperlipidemia
Interventions
DRUG

ProAlgaZyme

Trial Locations (1)

55435

MAPS Applied Research Center (MARC), Edina

Sponsors
All Listed Sponsors
collaborator

MAPS Applied Research Center

INDUSTRY

lead

Health Enhancement Products, Inc.

INDUSTRY

NCT00518960 - The Effects of ProAlgaZyme on HDL Cholesterol in Individuals With Metabolic Syndrome | Biotech Hunter | Biotech Hunter